Organic Process Research & Development
Article
NMR (CDCl3, 400 mHz) δ 0.66 (dt, 2H, J = 4.8, 6.4 Hz), 1.04
(dt, 2H, J = 4.8, 6.4 Hz), 1.23−1.33 (m, 2H), 1.37−1.45 (m,
1H), 1.54−1.62 (m, 2H), 1.71 (ddd (app dt), 1H, J = 6.8, 14
Hz), 1.98 (ddd (app dt), 1H, J = 7.2, 14.0 Hz), 2.14 (tt, 1H, J =
4.4, 7.6 Hz), 3.25−3.32 (m, 2H), 3.62 (dd (app t), 1H, J = 6.8
Hz), 3.91−3.93 (m, 2H), 7.21 (d, 2H, J = 8.4 Hz), 7.25 (d, 2H,
J = 8.4 Hz), 11.4−11.6 (br s, 1H). 13C NMR (CDCl3, 100
mHz) δ 8.5, 11.9, 32.4, 32.5, 32.9, 29.9, 47.7, 67.6, 67.7, 126.6,
128.3, 135.0, 138.3, 179.2. IR (film) 3100−2700 (br s), 2990,
2934, 1710, 1491, 1435, 1275, 1223, 1171, 1127, 1119, 1104,
1086, 1074, 1026, 1011, 978, 881, 859, 747 cm−1. HRMS (EI+)
calcd for C17H22O3S 306.12897, found 306.12858.
(R)-3 as a white solid with 82% ee as determined by chiral
HPLC.
1H NMR (DMSO-d6, 400 mHz) δ 0.99−1.05 (m, 2H),
1.06−1.19 (m, 4H), 1.26−1.33 (m, 1H), 1.50−1.60 (m, 2H),
1.63 (ddd, 1H, J = 7.2, 7.2, 14.0 Hz), 1.92 (ddd, 1H, J = 7.6, 7.6,
13.6 Hz), 2.82 (dddd (app tt), 1H, J = 4.8, 8.0 Hz), 3.11−3.18
(m, 2H) 3.73−3.80 (m, 3H), 7.57 (d, 2H, J = 8.4 Hz), 7.83 (d,
2H, J = 8.4 Hz), 12.54−12.60 (br s, 1H). 13C NMR (DMSO-d6,
100 mHz) δ 5.8, 32.4, 32.6, 32.8, 33.0, 48.0, 67.3, 127.9, 129.4,
139.6, 146.0, 174.6. IR (film) 3000−2600 (br s), 2916, 1718,
1316, 1294, 1272, 1223, 1190, 1149, 1130, 1089, 1071, 1037,
1015, 885, 855, 836, 822, 781, 758, 736 cm−1. HRMS (EI+)
calcd for C17H22O5S 338.11879, found 338.1183. [α]D24 −53.8
(MeOH, c = 2.8).
(R)-((R)-4,4-dimethyl-2-oxotetrahydrofuran-3-yl)-2-(4-
(cyclopropylthio)phenyl)-3-(tetrahydro-2H-pyran-4-yl)-
propanoate (4). Following a procedure reported in the
literature,7 to a solution of sulfide acid 5 (2.34 g, 7.64 mmol)
in toluene (46 mL) and DMF (10 μL) under a nitrogen
atmosphere was added oxalyl chloride (0.80 mL, 9.16 mmol).
The solution was stirred at 24 °C for 3 h, and then it was
cooled to 0 °C. Dimethylethylamine (2.49 mL, 22.91 mmol)
was added dropwise, and the solution was allowed to warm to
24 °C and stir for 2 h. The solution was cooled to −69 °C, and
a solution of (R)-pantolactone 6 (1.20 g, 9.16 mmol) in toluene
(37 mL) was added at such a rate to maintain the solution
temperature <−60 °C. The solution was allowed to stir and
warm to 24 °C slowly over 12 h. The reaction was quenched
with H2O, and the aqueous layer was separated. The organic
layer was washed with saturated NaHCO3 and brine, and the
aqueous layer was back extracted with EtOAc (2×). The
combined organic layers were dried over Na2SO4, filtered, and
concentrated in vacuo to give 3.14 g (98%) of 4 as a colorless
AUTHOR INFORMATION
■
Corresponding Author
Notes
The authors declare no competing financial interest.
REFERENCES
■
2012.
(3) Matschinsky, F. M. Nat. Rev. Drug Discovery 2009, 8, 399.
(4) (a) Cannizzaro, C. E.; Houk, K. N. J. Am. Chem. Soc. 2004, 126,
10992. (b) Silva, A. M.; da Silva, C. O.; Barbosa, A. G. H.; Fontes, R.
A.; Pinheiro, S.; Lima, M. E. F.; Castro, R. N. J. Braz. Chem. Soc. 2011,
22, 756.
1
oil with 88% de as determined by chiral HPLC. H NMR
(CDCl3, 400 mHz) δ 0.62−0.66 (m, 2H), 0.98 (s, 3H), 1.01−
1.05 (m, 2H), 1.09 (s, 3H), 1.23−1.34 (m, 2H), 1.42−1.53 (m,
1H), 1.58−1.62 (m, 2H), 1.77 (ddd (app dt), 1H, J = 7.2, 14.4
Hz), 2.05 (ddd, 1H, J = 6.8, 8.0, 14.0 Hz), 2.13 (dddd (app tt),
2H, J = 4.4, 7.2 Hz), 3.28 (ddd (app dt), 2H, J = 2.0, 11.6 Hz),
3.78 (dd, (app t), 1H, J = 8.0 Hz), 3.87−3.90 (m, 2H), 3.94−
3.99 (m, 2H), 5.28 (s, 1H), 7.22 (d, 2H, J = 8.4 Hz), 7.29 (d,
2H, J = 8.4 Hz). 13C NMR (CDCl3, 100 mHz) δ 8.5, 11.9, 19.8,
23.0, 32.6, 32.7, 32.9, 39.9, 40.2, 47.9, 67.7, 75.2, 76.0, 126.6,
128.3, 134.4, 138.3, 171.8, 172.6. IR (film) 2953, 2927, 1785,
1740, 1491, 1134, 1119, 1089, 1011, 996 cm−1. HRMS (EI+)
calcd for C23H30O5S 418.18139, found 418.18161. [α]D24 +4.58
(MeOH, c = 1.2).
(5) (a) Fyfe, M. C. T.; Gardner, L. S.; Nawano, M.; Procter, M. J.;
Rasamison, C. M.; Schofield, K. L.; Shah, V. K.; Yasuda, K. (OSI
Pharmaceuticals, Inc., USA; Prosidion Ltd., GB). PCT Int. Appl. WO/
2004/072031 A2 20040826, 2004. (b) Briner, P. H.; Fyfe, M. C. T.;
Madeley, J. P.; Murray, P. J.; Procter, M. J. (Prosidion Ltd., GB);
Spindler, F. (Solvias, AG). PCT Int. Appl.WO/2006/016178 A1
20060216, 2006. (c) For process development see: Magnus, N. A.;
Braden, T. M; Buser, J. Y.; DeBaillie, A. C.; Heath, P. C.; Ley, C. P.;
Remacle, J, R.; Varie, D. L.; Wilson, T. M. Org. Process Res. Dev. 2012,
16, 830.
(6) Larsen, R. D.; Corley, E. G.; Davis, P.; Reider, P. J.; Grabowski, E.
J. J. J. Am. Chem. Soc. 1989, 111, 7650.
(7) Chen, C.; Dagneau, P.; Grabowski, E. J. J.; Oballa, R.; O’Shea, P.;
Prasit, P.; Robichaud, J.; Tillyer, R.; Wang, X. J. Org. Chem. 2003, 68,
2633.
(R)-2-(4-(Cyclopropylsulfonyl)phenyl)-3-(tetrahydro-2H-
pyran-4-yl)propanoic Acid ((R)-3). To a 0 °C solution of
lithium hydroxide (29.7 mg, 1.24 mmol), hydrogen peroxide
(30%) (0.25 mL, 2.48 mmol), and H2O (0.16 mL) was added
sulfide ester 4 (0.13 g, 0.31 mmol) (82% de) in THF (0.49
mL) dropwise. The mixture was stirred at 0 °C for 2 h, and
then the bath was removed and the mixture was stirred for an
additional 5.5 h at 23 °C. A solution of saturated sodium sulfite
(2 mL) was added to the reaction mixture followed by H2O,
MTBE, and 1.0 M HCl (10 mL) (pH approx 1). The layers
were separated, and the aqueous layer was extracted with
MTBE (2 × 10 mL). The combined organic layers were
washed with saturated NaHCO3 (3 × 5 mL). Then 1.0 M HCl
was added to the combined basic aqueous layers until the pH
was approximately 1. The acidic aqueous solution was extracted
with MTBE, and the organic layer was dried over Na2SO4,
filtered, and concentrated in vacuo to give 0.086 g (82%) of
(8) For the asymmetric synthesis of (R)-1 from the racemic sulfone
acid and pantolactone see: Sugawara, K.; Toshikawa, S. (Mitsubishi
Tanabe Pharma Corporation, Japan). PCT Int. Appl. WO 2009139438
A1 20091119, 2009.
(9) (a) SciFinder search lists over 50 suppliers for (R)-pantolactone.
(b) Grabowski, E. J. J. (R)-Pantolactone. In e-EROS Encylcopedia of
Reagents for Organic Synthesis; Crich, D.; Charette, A. B.; Fuchs, P. L.;
Rovis, T.; John Wiley & Sons: New York, 2010.
(10) Bertram, L. S.; Black, D.; Briner, P. H.; Chatfield, R.; Cooke, A.;
Fyfe, M. C. T.; Murray, P. J.; Naud, F.; Nawano, M.; Procter, M. J.;
Rakipovski, G.; Rasamison, C. M.; Reynet, C.; Schofield, K. L.; Shah,
V. K.; Spindler, F.; Taylor, A.; Turton, R.; Williams, G. M.; Wong-Kai-
In, P.; Yasuda, K. J. Med. Chem. 2008, 51, 4340.
(11) Residual triphenylphosphine was removed during the aqueous
workup; see the Experimental Section.
(12) For an enantioselective hydrogenation of E- sulfide acrylic acid
10 see: Zhang, Y.; Han, Z.; Li, F.; Ding, K.; Zhang, A. Chem. Commun.
2010, 46, 156.
1542
dx.doi.org/10.1021/op300139g | Org. Process Res. Dev. 2012, 16, 1538−1543